Ontology highlight
ABSTRACT: Background
Elevated blood pressure is linked to cognitive impairment and Alzheimer's disease (AD) biomarker abnormality. However, blood pressure levels vary over time. Less is known about the role of long-term blood pressure variability in cognitive impairment and AD pathophysiology.Objective
Determine whether long-term blood pressure variability is elevated across the clinical and biomarker spectrum of AD.Methods
Alzheimer's Disease Neuroimaging Initiative participants (cognitively normal, mild cognitive impairment, AD [n = 1,421]) underwent baseline exam, including blood pressure measurement at 0, 6, and 12 months. A subset (n = 318) underwent baseline lumbar puncture to determine cerebrospinal fluid amyloid-β and phosphorylated tau levels. Clinical groups and bio
SUBMITTER: Sible IJ
PROVIDER: S-EPMC8054661 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature